{"id":309,"date":"2026-02-18T16:25:17","date_gmt":"2026-02-18T14:25:17","guid":{"rendered":"http:\/\/example.test\/?post_type=product&#038;p=309"},"modified":"2026-05-28T16:46:48","modified_gmt":"2026-05-28T13:46:48","slug":"tirzepatide-10-mg","status":"publish","type":"product","link":"https:\/\/life-peptide.com\/de\/product\/tirzepatide-10-mg\/","title":{"rendered":"Tirzepatid 10 mg"},"content":{"rendered":"<h4><strong>Research peptide targeting GLP-1 and GIP pathways for weight loss<\/strong><\/h4>\n<h4><strong>Product overview<\/strong><\/h4>\n<p>Tirzepatide is an investigational dual incretin receptor agonist designed to target both GLP-1 and GIP signaling pathways. This dual-receptor profile places it between traditional GLP-1 analogues and newer multi-agonist compounds, making it a central reference point in modern metabolic research.<br \/>\nBy engaging two key hormonal pathways involved in nutrient signaling and energy balance, Tirzepatide is widely studied in experimental models focused on appetite regulation, glucose metabolism, and systemic energy homeostasis. Its mechanism provides a broader signaling profile compared to single-pathway GLP-1 compounds, while remaining more selective than triple agonists such as Retatrutide.<br \/>\nResearchers often use Tirzepatide as a benchmark compound when comparing single, dual, and multi-receptor incretin strategies. For a deeper comparison across these classes, see the GLP-1 metabolic research guide.<\/p>\n<h4><strong>Research applications (investigational)<\/strong><\/h4>\n<p>Tirzepatide has been investigated in preclinical and experimental settings for its involvement in:<\/p>\n<ul>\n<li>Dual incretin receptor signaling (GLP-1 and GIP pathways)<\/li>\n<li>Glucose metabolism and insulin signaling dynamics<\/li>\n<li>Appetite regulation and satiety-related signaling mechanisms<\/li>\n<li>Energy balance and metabolic pathway modulation<\/li>\n<li>Hepatic and lipid metabolism signaling pathways<\/li>\n<li>Comparative analysis of single vs dual incretin receptor activation<\/li>\n<\/ul>\n<p>These areas reflect ongoing scientific investigation into metabolic signaling systems rather than established applications.<\/p>\n<h4><strong>Product characteristics<\/strong><\/h4>\n<p>Purity: \u226599% (HPLC-tested)<br \/>\nAppearance: Lyophilized white\/off-white powder<br \/>\nMolecular formula: C<sub>225<\/sub>H<sub>348<\/sub>N<sub>48<\/sub>O<sub>68<\/sub><br \/>\nMolecular weight: 4813.45<br \/>\nSequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(AEEA-AEEA-\u03b3-Glu-C20 diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2<br \/>\nStorage: store lyophilized powder at -20\u00b0C, protect from light and moisture. Reconstituted solution should be kept at 2\u20138\u00b0C and used within a short period.<\/p>\n<h4><strong>Why choose our Tirzepatide?<\/strong><\/h4>\n<p>\u2265 99% purity verified by HPLC.<br \/>\nProduced in GMP-compliant facilities under strict QC protocols.<br \/>\nEach batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).<br \/>\nFreeze-dried (lyophilized) for maximum stability and extended shelf life.<br \/>\nSealed in sterile vials, ready for reconstitution.<br \/>\nReconstitution: Must be reconstituted with <a href=\"https:\/\/life-peptide.com\/de\/product\/bac-10-ml\/\">bacteriostatic water<\/a> before use. GLP-1 class peptides are sometimes slow to dissolve and require very gentle reconstitution to avoid foaming or remaining slightly cloudy.<\/p>\n<h4>Selected research references<\/h4>\n<ul>\n<li>Jastreboff AM et al. <em>\u201cTirzepatide Once Weekly for the Treatment of Obesity.\u201d New England Journal of Medicine<\/em>, 2022.<\/li>\n<li>Frias JP et al. <em>\u201cTirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.\u201d New England Journal of Medicine<\/em>, 2021.<\/li>\n<li>Ludvik B et al. <em>\u201cOnce-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin.\u201d The Lancet<\/em>, 2021.<\/li>\n<li>Coskun T et al. <em>\u201cLY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.\u201d Molecular Metabolism,<\/em> 2018.<\/li>\n<li>ClinicalTrials.gov Identifier: NCT04184622 \u2014 <em>Tirzepatide research in obesity and metabolic signaling pathways.<\/em><\/li>\n<\/ul>\n<h4><strong>Related research context<\/strong><\/h4>\n<p>Tirzepatide is part of the dual incretin receptor agonist (GLP-1\/GIP) metabolic research class. For mechanistic comparison with single-pathway GLP-1 agonists and triple-agonist compounds, see our <strong><a href=\"http:\/\/example.test\/glp-1-metabolic-research-guide\/\" target=\"_blank\" rel=\"noopener\">Leitfaden zur Stoffwechselforschung von GLP-1<\/a>.<\/strong><\/p>\n<p>Browse all compounds in the <a href=\"\/de\/product-category\/metabolic-research\/\"><strong>Metabolic research category.<\/strong><\/a><\/p>\n<p>Researchers comparing multi-receptor activation may also examine:<\/p>\n<ul>\n<li data-start=\"2635\" data-end=\"2671\"><a href=\"http:\/\/example.test\/product\/retatrutide-10-mg\/\" target=\"_blank\" rel=\"noopener\">Retatrutide (GLP-1\/GIP\/glucagon triple-receptor agonist)<\/a><\/li>\n<li data-start=\"2674\" data-end=\"2702\"><a href=\"http:\/\/example.test\/product\/semaglutide-10-mg\/\" target=\"_blank\" rel=\"noopener\">Semaglutide (GLP-1 receptor agonist)<\/a><\/li>\n<\/ul>\n<p><strong>NOTE:<\/strong> This is for educational reference only and does not constitute medical advice.<\/p>\n<p><strong>Disclaimer:<\/strong><br \/>\nThis product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.<\/p>","protected":false},"excerpt":{"rendered":"<p>Tirzepatide is a synthetic dual incretin receptor agonist studied for interaction with GLP-1 and GIP pathways in metabolic research models.<\/p>\n<p>||<\/p>\n<p>HPLC Purity \u226599% | Lyophilized | Research grade | EU-based supply | Free EU shipping over \u20ac100<\/p>","protected":false},"featured_media":313,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[19],"product_tag":[249,144,139,250,251,247,252,246],"class_list":["post-309","product","type-product","status-publish","has-post-thumbnail","product_cat-metabolic-research-peptides","product_tag-appetite-pathways","product_tag-dual-agonist","product_tag-glp-1-research","product_tag-glp-1-gip-agonist","product_tag-glucose-research","product_tag-metabolic-peptide","product_tag-obesity-research","product_tag-weight-loss-peptide","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product\/309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/comments?post=309"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/media\/313"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/media?parent=309"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product_brand?post=309"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product_cat?post=309"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/life-peptide.com\/de\/wp-json\/wp\/v2\/product_tag?post=309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}